Alovudine
Overview of the antiretroviral drug Alovudine
Alovudine | |
---|---|
[[File:|frameless|220px|alt=|]] | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Overview[edit | edit source]
Alovudine is an antiretroviral drug used in the treatment of HIV/AIDS. It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs), which work by inhibiting the action of reverse transcriptase, an enzyme crucial for the replication of HIV.
Mechanism of Action[edit | edit source]
Alovudine is a thymidine analog that competes with the natural substrate, thymidine triphosphate, for incorporation into the viral DNA by reverse transcriptase. Once incorporated, it causes chain termination, thereby preventing the synthesis of viral DNA and subsequent replication of the virus.
Pharmacokinetics[edit | edit source]
Alovudine is administered orally and is absorbed in the gastrointestinal tract. It undergoes intracellular phosphorylation to its active triphosphate form. The drug is primarily excreted by the renal system.
Clinical Use[edit | edit source]
Alovudine is used in combination with other antiretroviral agents for the treatment of HIV-1 infection. It is not recommended as monotherapy due to the rapid development of resistance.
Side Effects[edit | edit source]
Common side effects of Alovudine include nausea, headache, and fatigue. More serious adverse effects can include lactic acidosis and hepatomegaly with steatosis.
Resistance[edit | edit source]
Resistance to Alovudine can develop through mutations in the reverse transcriptase enzyme. These mutations reduce the drug's efficacy, necessitating the use of combination therapy to prevent resistance.
Research and Development[edit | edit source]
Research is ongoing to improve the efficacy and safety profile of Alovudine, as well as to explore its use in combination with other antiretroviral drugs.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD